FOCUS: HIV
South Africa not on list for generic 'gamechanger' HIV drug
The US has approved lenacapavir as a twice-yearly injection to prevent HIV, but the game-changer drug remains out of reach for South Africans, who carry the world's highest burden of HIV. MedicalBrief writes that the drug is awaiting regulatory approval in South Africa but will be unaffordable for the vast majority of its citizens as the country is not among those to be supplied with generic versions.
Daniel O’Day, chairman and CEO of Gilead Sciences, called the approval of Yeztugo...